Prado, Silvia <br/><br/>
Bioavailable inhibitors of HIV-1 RNA biogenesis identified through a Rev-based screen.  [electronic resource] 

 -  Biochemical pharmacology  May 2016 
 - 14-28 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2968 
<br/><br/><label>Standard No.: </label>10.1016/j.bcp.2016.02.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-HIV Agents--adverse effects<br/>Cell Line<br/>Cell Survival--drug effects<br/>Clomiphene--adverse effects<br/>Cyproheptadine--adverse effects<br/>Drug Evaluation, Preclinical<br/>Gene Expression Regulation, Viral--drug effects<br/>Genes, Reporter--drug effects<br/>HIV-1--drug effects<br/>High-Throughput Screening Assays<br/>Humans<br/>Peptide Fragments--antagonists & inhibitors<br/>Protein Interaction Domains and Motifs<br/>RNA Splicing--drug effects<br/>RNA, Viral--metabolism<br/>Recombinant Proteins--chemistry<br/>Response Elements--drug effects<br/>Small Molecule Libraries<br/>Transcription, Genetic--drug effects<br/>rev Gene Products, Human Immunodeficiency Virus--antagonists & inhibitors